Nevertheless, cross-reactivity in antibody tests was reported between SARS-CoV-2 and dengue virus early in the pandemic, and dengue-like syndromes with thrombocytopenia and false IgM-positivity have been described (Nacher et al., 2020; Dutta et al., 2023). This evidence concerns the gene CD40LG and Thrombocytopenia.